De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?

De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?

Background and PurposeThe advanced glycation end products (AGEs) have been implicated in different diseases’ pathogenesis, but their role in hepatocellular carcinoma (HCC) is still a matter of debate. This study aims to investigate the association of AGEs with HCC development in patients with hepati...

Full description

Bibliographic Details
Main Authors: Ahmed Abdel-Razik, Walaa Shabana, Ahmed Mohamed El Nakib, Mostafa Abdelsalam, Ahmed Abdelwahab, Ahmad S. Hasan, Rasha Elzehery, Rania Elhelaly, Aya Ahmed Fathy, Sally Abdallah Mostafa, Niveen El-Wakeel, Dalia Moemen, Waleed Eldars, Ahmed H. Yassen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
hepatocellular carcinoma
direct-acting antivirals
hepatitis C virus
advanced glycation end products
liver cirrhosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.662431/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2021.662431/full

Similar Items